The relationship between smoking, psoriasis and psoriatic arthritis E Pezzolo, L Naldi Expert Review of Clinical Immunology 15 (1), 41-48, 2019 | 67 | 2019 |
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience P Gisondi, S Piaserico, L Naldi, P Dapavo, A Conti, P Malagoli, ... Journal of Allergy and Clinical Immunology 147 (2), 558-560. e1, 2021 | 64 | 2021 |
Epidemiology of major chronic inflammatory immune-related skin diseases in 2019 E Pezzolo, L Naldi Expert review of clinical immunology 16 (2), 155-166, 2020 | 62 | 2020 |
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the … A Sechi, E Pierobon, E Pezzolo, L Germi, G Trevisan, D Zardo, G Riva, ... Clinical and Experimental Dermatology 47 (2), 437-440, 2022 | 47 | 2022 |
Heat urticaria: a revision of published cases with an update on classification and management E Pezzolo, A Peroni, P Gisondi, G Girolomoni British Journal of Dermatology 175 (3), 473-478, 2016 | 47 | 2016 |
Characterization of hidradenitis suppurativa phenotypes: a multidimensional latent class analysis of the National Italian Registry IRHIS S Cazzaniga, E Pezzolo, V Bettoli, D Abeni, AV Marzano, A Patrizi, ... Journal of Investigative Dermatology 141 (5), 1236-1242. e1, 2021 | 32 | 2021 |
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy P Gisondi, E Pezzolo, G Lo Cascio, G Girolomoni British Journal of Dermatology 171 (4), 884-890, 2014 | 32 | 2014 |
Dupilumab treatment in children aged 6–11 years with atopic dermatitis: a multicentre, real-life study M Napolitano, G Fabbrocini, I Neri, L Stingeni, V Boccaletti, V Piccolo, ... Pediatric Drugs 24 (6), 671-678, 2022 | 30 | 2022 |
Psoriasis incidence and lifetime prevalence: suggestion for a higher mortality rate in older age-classes among psoriatic patients compared to the general population in Italy E Pezzolo, S Cazzaniga, P Colombo, L Chatenoud, L Naldi Acta dermato-venereologica 99 (4), 400-403, 2019 | 30 | 2019 |
Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study E Pezzolo, U Mutlu, MW Vernooij, EA Dowlatshahi, P Gisondi, ... Journal of the American Academy of Dermatology 85 (3), 671-680, 2021 | 29 | 2021 |
Tralokinumab in the treatment of resistant atopic dermatitis: An open‐label, retrospective case series study. E Pezzolo, L Naldi Journal of the European Academy of Dermatology & Venereology 37 (5), 2023 | 16 | 2023 |
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: a multicentre real-world study E Pezzolo, D Schena, A Gambardella, M Rossi, F Barei, ... Journal of the European Academy of Dermatology and Venereology 38 (1), 11-13, 2024 | 14 | 2024 |
Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: a case series G Licata, V Tancredi, E Pezzolo, G Pertusi, E Tolino, M Arisi, ... Journal of the European Academy of Dermatology and Venereology 37 (8), e1064 …, 2023 | 9 | 2023 |
Preheated autologous serum skin test in localized heat urticaria E Pezzolo, A Peroni, D Schena, G Girolomoni Clinical and Experimental Dermatology 39 (8), 921-923, 2014 | 9 | 2014 |
Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study E Pezzolo, A Gambardella, M Guanti, T Bianchelli, A Bertoldi, A Giacchetti, ... Journal of the American Academy of Dermatology 89 (2), 430-432, 2023 | 8 | 2023 |
Efficacy and safety of Dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real‐world clinical experience. E Pezzolo, S Cazzaniga, S Di Leo, L Naldi, G Altomare, G Annali, ... Journal of the European Academy of Dermatology & Venereology 36 (7), 2022 | 8 | 2022 |
Long‐term drug survival of dupilumab and associated predictors in moderate‐to‐severe atopic dermatitis: A real‐world prospective cohort study. E Pezzolo, MT Rossi, F Caroppo, T Bianchelli, A Belloni Fortina, ... Journal of the European Academy of Dermatology & Venereology 37 (6), 2023 | 7 | 2023 |
Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study F Bellinato, P Gisondi, AV Marzano, S Piaserico, C De Simone, ... Vaccines 11 (4), 740, 2023 | 6 | 2023 |
Late-onset hidradenitis suppurativa: a cluster analysis of the National Italian Registry IRHIS S Cazzaniga, E Pezzolo, S Garcovich, L Naldi, V Bettoli, D Abeni, ... Journal of the American Academy of Dermatology 85 (1), e29-e32, 2021 | 6 | 2021 |
Psoriasis severity matters when dealing with all-cause mortality in psoriasis patients: a record linkage analysis in Northern Italy E Pezzolo, R Ciampichini, S Cazzaniga, G Sampietro, A Zucchi, L Naldi Archives of dermatological research 313 (4), 255-261, 2021 | 6 | 2021 |